The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis
- 25 August 2005
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 153 (5) , 911-918
- https://doi.org/10.1111/j.1365-2133.2005.06800.x
Abstract
Background Interleukin (IL)-20 and IL-19 are recently discovered members of the IL-10 family of cytokines. The skin of transgenic mice overexpressing IL-20 shows histological changes resembling some of those seen in psoriasis, i.e. thickened epidermis, hyperkeratosis and a compact stratum corneum. IL-19 and IL-20, as well as their receptor complexes, IL-20Rα/IL-20Rβ and IL-22Rα/IL-20Rβ, are expressed in human skin. Objectives To study the dynamics of IL-19 and IL-20 gene expression as well as the expression of their receptor subunits in psoriatic skin lesions. Methods Punch biopsies from patients with plaque-type psoriasis were collected before, during and after 28 days of treatment with either calcipotriol or ciclosporin (CsA). IL-20, IL-19, IL-20Rα, IL-20Rβ and IL-22Rα mRNA expression were determined by quantitative reverse transcriptase–polymerase chain reaction. Results We found IL-19 and IL-20 mRNA expression in lesional psoriatic skin to be strongly upregulated compared with nonlesional psoriatic skin by a factor of 65 and 22, respectively. In contrast to previous reports, IL-20Rα and IL-20Rβ mRNA levels showed a modest but statistically significant decrease in lesional psoriatic skin compared with nonlesional psoriatic skin. During treatment with calcipotriol or CsA, IL-19 and IL-20 mRNA levels decrease in accordance with the clinical improvement of psoriasis. Neither IL-19, IL-20, nor receptor subunit mRNA expression in lesional psoriatic skin reaches the levels of nonlesional skin during this short-term treatment. These findings are in line with the residual disease activity observed at the end of treatment. Conclusions The increased IL-19 and IL-20 mRNA expression levels in lesional psoriatic skin suggest that these two cytokines play a role in the pathogenesis of psoriasis. An imbalance in the receptor complexes for IL-19 and IL-20 might contribute to their suspected pathogenic effects.Keywords
This publication has 18 references indexed in Scilit:
- The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T‐cell subsets in chronic plaque psoriasisExperimental Dermatology, 2004
- Epidermal Overexpression of Interleukin-19 and -20 mRNA in Psoriatic Skin Disappears After Short-Term Treatment with Cyclosporine A or CalcipotriolJournal of Investigative Dermatology, 2003
- Selective enhancement of multipotential hematopoietic progenitors in vitro and in vivo by IL-20Blood, 2003
- Crystal Structure of Interleukin-19 Defines a New Subfamily of Helical CytokinesJournal of Biological Chemistry, 2003
- Interleukins 19, 20, and 24 Signal through Two Distinct Receptor ComplexesJournal of Biological Chemistry, 2002
- The family of IL-10-related cytokines and their receptors: related, but to what extent?Cytokine & Growth Factor Reviews, 2002
- Localization of Calcineurin/NFAT in Human Skin and Psoriasis and Inhibition of Calcineurin/NFAT Activation in Human Keratinocytes by Cyclosporin AJournal of Investigative Dermatology, 2002
- Interleukin 20Cell, 2001
- Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assaysJournal of Molecular Endocrinology, 2000
- Cloning, expression and initial characterisation of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10)Genes & Immunity, 2000